IMMUNPHETONYPING PANEL REPOSITIONING: NEW WAYS TO ANALYZE ACUTE MYELOID LEUKEMIA BIOMARKERS AND THEIR RELEVANCE

One of the greatest obstacles in the treatment of Acute Myeloid Leukemia (AML) is relapse, occurring in 40-50% of younger patients and most elderly patients. The Leukemia Stem Cells (LSCs) model suggests that only a small population of cancer cells is responsible for treatment resistance and recurre...

Full description

Bibliographic Details
Main Authors: CK Dias, HC Alves, MFGM Fernandes, AN Sant'ana, MG Farias, AP Alegretti, PP Silva, LE Daudt, AA Paz, MB Michalowski, F Figueiró
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137923004984